• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.

作者信息

Appelbaum Frederick R

出版信息

J Clin Oncol. 2008 Jun 20;26(18):2927-9. doi: 10.1200/JCO.2007.15.7479.

DOI:10.1200/JCO.2007.15.7479
PMID:18565876
Abstract
摘要

相似文献

1
Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.非霍奇金淋巴瘤的造血细胞移植：过去、现在与未来。
J Clin Oncol. 2008 Jun 20;26(18):2927-9. doi: 10.1200/JCO.2007.15.7479.
2
[Treatment of Hodgkin's lymphoma and hematopoietic cell autotransplantation].[霍奇金淋巴瘤的治疗与造血细胞自体移植]
Rev Invest Clin. 2001 Nov-Dec;53(6):552-60.
3
Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?哪些复发的非霍奇金淋巴瘤患者能从高剂量治疗和造血干细胞移植中获益？
J Clin Oncol. 1993 Oct;11(10):1841-3. doi: 10.1200/JCO.1993.11.10.1841.
4
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.自体干细胞移植用于高危侵袭性非霍奇金淋巴瘤的一线治疗。
Neoplasma. 2008;55(2):107-12.
5
Advances in treating lymphatic cancer. High-dose chemotherapy plus stem-cell support improves survival for some people with non-Hodgkin's lymphoma.
Health News. 2004 May;10(5):4-5.
6
Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.拉米夫定预防晚期或复发非霍奇金淋巴瘤患者大剂量化疗及自体造血干细胞移植后乙肝病毒再激活：单中心经验
Expert Opin Pharmacother. 2009 Oct;10(15):2399-406. doi: 10.1517/14656560903251710.
7
[Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?].[中枢神经系统原发性非霍奇金淋巴瘤。治疗中仍是问题多于答案？]
Ugeskr Laeger. 2007 Jun 4;169(23):2187-9.
8
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.侵袭性非霍奇金淋巴瘤大剂量造血干细胞移植治疗国际共识会议：评审团报告
J Clin Oncol. 1999 Jan;17(1):423-9. doi: 10.1200/JCO.1999.17.1.423.
9
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.在老年非霍奇金淋巴瘤患者中采用剂量降低的白消安（BU）和环磷酰胺（CY）方案进行自体造血干细胞移植。
Bone Marrow Transplant. 2009 Jan;43(1):37-42. doi: 10.1038/bmt.2008.298. Epub 2008 Sep 15.
10
FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation.FCGR3A-158V/F基因多态性可能与非霍奇金淋巴瘤患者在接受利妥昔单抗作为自体干细胞移植辅助治疗后的免疫球蛋白水平相关。
Eur J Haematol. 2009 Feb;82(2):143-7. doi: 10.1111/j.1600-0609.2008.01174.x. Epub 2008 Nov 6.

引用本文的文献

1
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients.关于BEAM方案与FEAM方案预处理对淋巴瘤患者中性粒细胞减少性小肠结肠炎发生率及移植结局影响的前瞻性研究。
Front Oncol. 2024 May 13;14:1369601. doi: 10.3389/fonc.2024.1369601. eCollection 2024.
2
Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS.全印度医学科学研究所中BEAM方案与LEAM方案用于淋巴瘤自体移植的比较。
Springerplus. 2013 Sep 26;2:489. doi: 10.1186/2193-1801-2-489. eCollection 2013.
3
Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
首次复发时的外周血淋巴细胞/单核细胞比值可预测复发或原发性难治性弥漫性大B细胞淋巴瘤患者的预后。
BMC Cancer. 2014 May 19;14:341. doi: 10.1186/1471-2407-14-341.
4
Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma - novel and emerging therapies.复发或难治性非霍奇金淋巴瘤的治疗挑战 - 新型和新兴疗法。
Cancer Manag Res. 2013 Aug 23;5:251-69. doi: 10.2147/CMAR.S34273. eCollection 2013.
5
Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.吉西他滨、长春瑞滨、脂质体多柔比星（GVD）14 天方案作为挽救方案治疗既往大量治疗的霍奇金淋巴瘤和侵袭性非霍奇金淋巴瘤患者具有良好的长期疗效。
Med Oncol. 2013 Mar;30(1):350. doi: 10.1007/s12032-012-0350-5. Epub 2013 Jan 18.